. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679-89. 2. Tutunchi H, Saghafi‐Asl M, Ostadrahimi A. A systematic review of the effects of oleoylethanolamide, a high‐affinity endogenous ligand of PPAR‐α, on the management and prevention of obesity. Clin Exp Pharmacol Physiol. 2020;47(4):543-52. 3. Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease Role Of Stearoyl-Coa Desaturase. J Biol Chem. 2009;284(9):5637-44. 4. Cariou B, Byrne CD, Loomba R, Sanyal AJ. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obes Metab. 2021;23(5):1069-83. 5. Zhang Y, Zhou G, Chen Z, Guan W, Zhang J, Bi M, et al. Si-Wu-Tang alleviates nonalcoholic fatty liver disease via blocking TLR4-JNK and caspase-8-GSDMD signaling pathways. Evid based Complement Alternat Med. 2020;2020. 6. Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur J Sport Sci. 2019;19(7):994-1003. 7. Perdomo CM, Frühbeck G, Escalada J. Impact of nutritional changes on nonalcoholic fatty liver disease. Nutrients. 2019;11(3):677. 8. Tutunchi H, Ostadrahimi A, Saghafi‐Asl M, Maleki V. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obes Rev. 2019;20(7):1057-69. 9. Wong VW-S, Chan RS-M, Wong GL-H, Cheung BH-K, Chu WC-W, Yeung DK-W, et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2013;59(3):536-42. 10. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012;56(1):255-66. 11. Gibala MJ, Little JP, MacDonald MJ, Hawley JA. Physiological adaptations to low‐volume, high‐intensity interval training in health and disease. J Physiol. 2012;590(5):1077-84. 12. Hottenrott K, Ludyga S, Schulze S. Effects of high intensity training and continuous endurance training on aerobic capacity and body composition in recreationally active runners. J Sports Sci Med. 2012;11(3):483. 13. Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectr. 2015;28(1):39-44. 14. Hsu W-F, Sheen L-Y, Lin H-J, Chang H-H. A review of Western and traditional Chinese medical approaches to managing nonalcoholic fatty liver disease. Evid Based Complement Alternat Med. 2016;2016:6491420. 15. Zarei A, Changizi